{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:32:21Z","timestamp":1789619541207,"version":"build-2803163510"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Novo Nordisk A\/S"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40262-023-01223-9","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T19:02:51Z","timestamp":1679079771000},"page":"635-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects"],"prefix":"10.1007","volume":"62","clinical-trial-number":[{"clinical-trial-number":"nct04513704","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5753-9563","authenticated-orcid":false,"given":"Marloes","family":"van Hout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-7067","authenticated-orcid":false,"given":"Pablo","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-9374","authenticated-orcid":false,"given":"Thomas B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-7038","authenticated-orcid":false,"given":"Cristina","family":"Boschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-0352","authenticated-orcid":false,"given":"Tine A.","family":"B\u00e6kdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"1223_CR1","unstructured":"US Food and Drug Administration. Rybelsus\u00ae (semaglutide) tablets: prescribing information; 2023. https:\/\/www.accessdata.fda.gov\/spl\/data\/fa74bbc6-5386-425e-8d4a-6151795ba57b\/fa74bbc6-5386-425e-8d4a-6151795ba57b.xml. Accessed March 31, 2022."},{"issue":"467","key":"1223_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar7047","volume":"10","author":"ST Buckley","year":"2018","unstructured":"Buckley ST, B\u00e6kdal TA, Vegge A, Maarbjerg SJ, Pyke C, Ahnfelt-Ronne J, et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med. 2018;10(467):eaar7047. https:\/\/doi.org\/10.1126\/scitranslmed.aar7047.","journal-title":"Sci Transl Med"},{"issue":"7","key":"1223_CR3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s13300-021-01078-y","volume":"12","author":"TA Baekdal","year":"2021","unstructured":"B\u00e6kdal TA, Breitschaft A, Donsmark M, Maarbjerg SJ, Sondergaard FL, Borregaard J. Effect of various dosing conditions on the pharmacokinetics of oral semaglutide, a human glucagon-like peptide-1 analogue in a tablet formulation. Diabetes Ther. 2021;12(7):1915\u201327. https:\/\/doi.org\/10.1007\/s13300-021-01078-y.","journal-title":"Diabetes Ther"},{"issue":"10","key":"1223_CR4","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/jcph.1131","volume":"58","author":"TA Baekdal","year":"2018","unstructured":"B\u00e6kdal TA, Thomsen M, Kupcova V, Hansen CW, Anderson TW. Pharmacokinetics, safety, and tolerability of oral semaglutide in subjects with hepatic impairment. J Clin Pharmacol. 2018;58(10):1314\u201323. https:\/\/doi.org\/10.1002\/jcph.1131.","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"1223_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/17425255.2018.1488965","volume":"14","author":"TA Baekdal","year":"2018","unstructured":"B\u00e6kdal TA, Breitschaft A, Navarria A, Hansen CW. A randomised study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide. Expert Opin Drug Metab Toxicol. 2018;14(8):869\u201377. https:\/\/doi.org\/10.1080\/17425255.2018.1488965.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"1223_CR6","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s40262-018-0649-2","volume":"57","author":"C Granhall","year":"2018","unstructured":"Granhall C, Sondergaard FL, Thomsen M, Anderson TW. Pharmacokinetics, safety and tolerability of oral semaglutide in subjects with renal impairment. Clin Pharmacokinet. 2018;57(12):1571\u201380. https:\/\/doi.org\/10.1007\/s40262-018-0649-2.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"1223_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1080\/17425255.2021.1955856","volume":"17","author":"C Hauge","year":"2021","unstructured":"Hauge C, Breitschaft A, Hartoft-Nielsen ML, Jensen S, B\u00e6kdal TA. Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial. Expert Opin Drug Metab Toxicol. 2021;17(9):1139\u201348. https:\/\/doi.org\/10.1080\/17425255.2021.1955856.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"1223_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10928-021-09751-2","volume":"48","author":"VS Ayyar","year":"2021","unstructured":"Ayyar VS, Sukumaran S. Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions. J Pharmacokinet Pharmacodyn. 2021;48(3):321\u201338. https:\/\/doi.org\/10.1007\/s10928-021-09751-2.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"1223_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0016-5085(87)90913-9","volume":"93","author":"RH Goo","year":"1987","unstructured":"Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology. 1987;93(3):515\u20138. https:\/\/doi.org\/10.1016\/0016-5085(87)90913-9.","journal-title":"Gastroenterology"},{"issue":"6453","key":"1223_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1126\/science.aax7621","volume":"365","author":"MD Ruben","year":"2019","unstructured":"Ruben MD, Smith DF, FitzGerald GA, Hogenesch JB. Dosing time matters. Science. 2019;365(6453):547\u20139. https:\/\/doi.org\/10.1126\/science.aax7621.","journal-title":"Science"},{"issue":"8","key":"1223_CR11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/dom.14054","volume":"22","author":"TK Thethi","year":"2020","unstructured":"Thethi TK, Pratley R, Meier JJ. Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: the PIONEER programme. Diabetes Obes Metab. 2020;22(8):1263\u201377. https:\/\/doi.org\/10.1111\/dom.14054.","journal-title":"Diabetes Obes Metab"}],"updated-by":[{"DOI":"10.1007\/s40262-023-01276-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000}}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-023-01223-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T12:02:50Z","timestamp":1687953770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-023-01223-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1007\/s40262-023-01223-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40262-023-01276-w","asserted-by":"object"}]},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"8 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40262-023-01276-w","URL":"https:\/\/doi.org\/10.1007\/s40262-023-01276-w","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial and medical writing support for the publication were funded by Novo Nordisk A\/S, S\u00f8borg, Denmark.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"MvH, TBJ, CB, and TAB are employees, and MvH, TBJ, and TAB are shareholders, of Novo Nordisk A\/S, the sponsors of this trial. PF is an employee of PAREXEL International.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data are available upon reasonable request. Data will be shared with bona fide researchers submitting a research proposal approved by the independent review board. Access request proposals can be found at novonordisk-trials.com. Data will be made available after research completion, and approval of the product and product use in the European Union and the USA. Individual participant data will be shared in data sets in a de-identified\/anonymised format.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The trial was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The protocol was approved by an independent ethics committee (South Central\u2014Berkshire B Research Ethics Committee).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All participants provided written informed consent.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"MvH, TAB, CB, and TBJ designed the trial; PF, MvH, TAB, and TBJ conducted the trial\/performed data collection; CB, TAB, TBJ, and MvH analysed the data; all authors drafted and revised the manuscript and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}